D2 Autoreceptors Chronically Enhance Dopamine Neuron Pacemaker Activity

doi:10.1523/JNEUROSCI.4976-05.2006

Midbrain dopamine (DA) neurons are important in normal motor control, cognitive function and reward behavior, and impairment of their function is involved in neurological and psychiatric diseases, such as Parkinson’s disease, schizophrenia and drug addiction (; ; ; ; , ). Repetitive DA neuron firing, which serves as the baseline for detection of bursts that encode unexpected reward (Schultz, , ), reflects the interplay of voltage-gated ion channels that generate intrinsic pacemaker activity and synaptic inputs. In addition to typical glutamatergic and GABAergic synapses, DA neurons are influenced by D2 autoreceptors that induce rapid hyperpolarization via activation of K⁺ channels (; ; ). The significance of this acute negative feedback is revealed by the acute DA neuron excitation induced by D2 antagonists (Pucak and Grace, , ; Werkman et al., 2001).

Recently, it was found that DA neuron intrinsic pacemaker activity is subject to long-term regulation. Specifically, in vivo treatment with the antipsychotic drug haloperidol for 5 or 6 days persistently reduces the rate and regularity of spontaneous firing of isolated DA neurons (). The change in rate was attributed to upregulation of A-type K⁺ channels, but the basis for more inconsistent pacing, which has also been seen in vivo with extracellular recordings (), is not understood. The change in regularity could reflect an increase in channel noise (), but upregulating A-type K⁺ channels would reduce the noise in the macroscopic A-type current. Hence, many channel types could be involved in long-term regulation of DA neurons. Although the biophysical basis of this effect remains unclear, long-term modulation of pacemaking could influence responses to reward and the effects of therapeutic and addictive drugs.

Mechanistically, the remodeling of DA neuron excitability has not seemed approachable because lesion experiments led to the conclusion that long-term effects on DA neurons require intact feedback circuitry () and so cannot be studied in vitro. An alternative interpretation is that lesions perturb conditions that are permissive for more direct effects on DA neurons. With this hypothesis in mind, we studied primary cultures of dissociated midbrain DA neurons that lack native synaptic targets and anatomical cues required for organized circuitry. We show that the delayed and sustained regulation of DA neuron pacemaking activity by haloperidol induced in vivo is recapitulated in vitro. We then use this experimental system along with the dynamic clamp technique to determine how pacemaking is controlled on the time scale of days. Unexpectedly, long-term regulation of K⁺ channel number is responsible for both the changes in rate and regularity, and D2 autoreceptors and cAMP alter channel number in a manner that counters their short-term effects on channel gating (; ; ). Thus, the time scale of signal integration determines whether the action of D2 autoreceptors/cAMP signaling is excitatory or inhibitory.

Materials and Methods

Cell preparation and drug treatment

The ventral mesencephalon was dissected from postnatal day 1 Sprague Dawley rats using a previously described method (). Dissected tissue pooled from a litter was incubated with 20 U/ml papain (Worthington Biochemicals) at 37 °C for 1 hour. The tissue was triturated using a fire-polished pasteur pipette in trituration solution: Basal Medium Eagle with 1mg/ml each of trypsin inhibitor and bovine serum albumin, 20 mM glucose, 10 mM HEPES, pH 7.3. The suspension of dissociated cells was then layered on top of centrifugation solution (BME with 10 mg/ml each trypsin inhibitor and bovine serum albumin) and spun for 8 min at 200 g. The pellet was resuspended in trituration solution and the yield was determined by counting cells with a hemocytometer. 35,000 cells were plated on 31 mm polylysine-coated glass coverslips. Cultures were maintained in a humid atmosphere of 5% CO₂/95% air at 37 °C, and were fed twice weekly with feeding medium (BME with N2 supplement (Gibco), penicillin/streptomycin, 2% rat serum, 0.6 mM glutamine, 10 mM glucose, and 10 mM HEPES, pH 7.3) until recordings were performed on 12 to 14 day old cultures. For chronic treatment experiments, compounds or vehicle were added at 7 or 8 days after generation of cultures, and replenished with changes in medium every 3 or 4 days until recordings were performed 5 or 6 days later. For 1 day sulpiride treatments, the drug or vehicle was added a day before recording from 12 to 14 day old cultures. When multiple compounds were required, they were added simultaneously. 100 nM haloperidol (Research Biochemicals) was added to medium from 100 μM stock solution and 1 μM sulpiride (Tocris) was added to medium from 1 mM stock solution in 70 % ethanol and tyrode solution (1:10). Quinpirole, 8-bromo-adenosine 3,5-cyclic monophosphate (8-Br-cAMP) and H-89 (Sigma) were dissolved in water and used at final concentrations of 1 μM, 1 mM and 1 μM, respectively.

Electrophysiology

DA neurons were identified by fluorescence after loading with 5,7-dihydroxytrpytamine with a 40x/340 UV Olympus objective using 340 nm light for excitation and a 420 nm long pass filter for emission fluorescence (; ; ). These cells spontaneously fired long-duration action potentials followed by marked afterhyperpolarizations, as has been shown in acutely dissociated midbrain DA neurons (). Conventional whole cell recordings, with 5-6 MΩ of series resistance, were performed in current clamp and voltage clamp modes at room temperature. Leak subtraction was performed with p/5 protocols, and 70% series resistance compensation was used with conventional patch clamp recordings. Electrodes were filled with a solution containing (in mM): 130 KCl, 4 MgCl₂, 1 CaCl₂, 10 EGTA, 10 HEPES, 2 ATP, pH 7.4. The bath solution contained (in mM): 150 NaCl, 4 KCl, 2 CaCl₂, 1 MgCl₂, 10 glucose, 10 HEPES, pH 7.4, and a cocktail of synaptic transmission blockers (50 μM AP-5, 10μM CNQX, 50 μM picrotoxin). However, for measurements of steady state A-type channel inactivation and recovery from inactivation, the bath solution was supplemented with 50 mM tetraethylammonium and the pipette solution contained 140 mM KCl, 2 mM MgCl₂, 1 mM EGTA, and 10 mM HEPES, pH 7.4. Thus, all recordings were performed in the absence of D2 receptor and cAMP/PKA drugs so that only persistent effects of pretreatments were detected.

The dynamic clamp setup and the virtual dopamine neuron A-type K⁺ conductance have been described previously (). Notably, to avoid problems with current clamp and series compensation associated with some patch clamp amplifiers, a true current clamp (Axoclamp 2B) equipped with a bridge circuit was used in dynamic clamp experiments (). Virtual channels, modeled on previous measurements from DA neurons () as described previously (), are quantified in terms of

, the maximum conductance in the gating model.

In perforated patch clamp recordings, patch pipettes were tip filled with a solution consisting of (in mM): 140 K-gluconate, 5 KCl, 10 HEPES, 0.1 EGTA, 2 MgCl₂, pH 7.35, and backfilled with the same solution containing amphotericin B (0.4 mg/ml). After access resistance had dropped to < 20 MΩ, firing activity was recorded in episodes (20 to 60 s) alternating without and with the dynamic clamp engaged. Because spontaneous pacemaker activity of perforated patch clamped cultured dopamine neurons is slow (), a small DC current (20 to 70 pA) was injected to increase firing rate to between 0.5 and 2 Hz. Regardless of firing rate, adding or subtracting virtual A-type channels with the dynamic clamp affected rate and regularity of action potential activity in every DA neuron tested.

Data are expressed as mean ± SEM. Statistical significance of paired comparisons was assessed by Student’s t-test unless otherwise indicated.

Results

The long-term in vivo effects of haloperidol are recapitulated by DA neurons in culture.

In order to emulate prior in vivo experiments (), spontaneous rhythmic activity was measured from 12-14 day old DA neuron cultures that had been treated with vehicle or 100 nM haloperidol for 5 or 6 days. Whole cell recordings from identified DA neurons, performed in the absence of haloperidol to reveal persistent effects, showed that the chronic application of haloperidol decreased spontaneous firing (Figure 1A, B). Interspike interval (ISI) histograms display a rightward shift in the peak and a widening of the distribution (Figure 1C, D). Data from independent experiments show that the induction of slower firing (quantified as the mean ISI; vehicle: 208.7 ± 45 ms; chronic Hal: 550 ± 93 ms; p < 0.05) and more irregular spontaneous pacemaker activity (quantified as the coefficient of variation in the ISI (CV_ISI); vehicle: 0.29 ± 0.05; chronic Hal; 0.67 ± 0.08; p < 0.01) is reproducible (Figure 1E, F). Thus, the alteration of DA neuron pacemaker activity originally identified with in vivo drug treatment is reproduced in vitro, showing that this plasticity does not depend on the organized connectivity found in the brain.

Figure 1

Chronic haloperidol treatment alters DA neuron intrinsic pacemaker activity in vitro. Whole-cell current clamp recordings from cultured DA neurons treated with vehicle (A) or haloperidol (B, chronic Hal) for 6 days. Spontaneous firing activity was recorded (more ...)

D2 autoreceptors produce the long-term changes in DA neuron excitability

The mechanism of haloperidol’s long-term effect on DA neuron pacemaker activity was unknown because this drug blocks many types of channels and receptors. However, therapeutic efficacy has been attributed to antagonism of D2 receptors. D2 receptors are present both on postsynaptic targets and on the DA neurons themselves, but the only neurons that express D2 receptors in our midbrain cultures are the DA neurons. Since these autoreceptors are acutely inhibitory, one would expect a D2 antagonist to be excitatory, which contrasts with the effect in Figure 1. Nevertheless, to test for involvement of D2 autoreceptors, we examined the effect of pretreatment with the selective D2 antagonist sulpiride.

As can be seen from representative whole-cell current clamp recordings (Figure 2A, B) and the accompanying histograms (Figure 2C, D), chronic treatment with 1 μM sulpiride slowed spontaneous pacemaker activity. Quantitative analysis of intrinsic activity showed that the ISI and the CV_ISI each changed, again indicating less firing (Figure 2E, ISI; vehicle: 314.8 ± 89 ms; chronic Sul: 805.3 ± 172 ms; p < 0.05) and more irregular activity (Figure 2F, CV_ISI; vehicle: 0.37 ± 0.06; chronic Sul: 0.75 ± 0.11; p <0.05). Thus, these results indicated for the first time that D2 autoreceptors could be responsible for the long-term effect on intrinsic excitability.

Figure 2

Chronic sulpiride treatment mimics the haloperidol effect on DA neuron intrinsic pacemaker activity. Whole-cell current clamp recording from cultured DA neurons treated with vehicle (A) and sulpiride (B, chronic Sul) for 6 days. Spontaneous firing activity (more ...)

If this conclusion is correct, then sulpiride and haloperidol should share the same molecular targets. Current clamp recordings from cultured DA neurons treated with sulpiride showed increases in the latency to the first action potential (vehicle: 178 ± 36 ms; chronic Sul: 501 ± 138 ms; p < 0.05) and in the first interspike interval (vehicle:109.2 ± 23 ms; chronic Sul: 201 ± 32 ms; p < 0.05) after releasing clamped neurons from a negative potential, -80 mV (Figure 3A). Since these effects are consistent with enhanced A-type K⁺ channel activity, we performed whole cell voltage clamp recordings to determine whether chronic sulpiride changes A-type K⁺ current. Treatment with sulpiride for 1 day did not affect A-type K⁺ current density (vehicle: 264 ± 44 pA/pF, n = 7; chronic Sul: 224 ± 31 pA/pF, n = 8), but the peak amplitude of this transient current increased in DA neurons treated with sulpiride for 5 or 6 days (Figure 3B). Indeed, A-type K⁺ current density significantly increased (vehicle: 381.4 ± 39 pA/pF; chronic Sul: 593.9 ± 42 pA/pF; p < 0.05), while there was no statistically significant change in non-inactivating outward current density with chronic sulpiride treatment (Figure 3C; vehicle: 248.2 ± 39 pA/pF; chronic Sul: 320.5 ± 33 pA/pF; p > 0.05). DA neuron A-type K⁺ current density was also increased by chronic haloperidol treatment (Figure 3D; vehicle: 375.7 ± 40 pA/pF; chronic Hal: 557 ± 67 pA/pF; p < 0.05). The regulation of the same channel type by haloperidol and sulpiride further suggests that D2 autoreceptors induce the long-term change in DA neuron excitability.

Figure 3

Chronic sulpiride treatment increases A-type K⁺ current in DA neurons. A, Left, Whole-cell current clamp recordings from cultured DA neurons treated with vehicle or sulpiride (chronic Sul) for 6 days. Spontaneous activity was recorded when current clamp (more ...)

Use of a selective D2 agonist verified the involvement of D2 receptors. If the long-term control of A-type K⁺ channels by sulpiride is mediated by blocking D2 autoreceptors, then a selective D2 agonist such as quinpirole should interfere with the effect of this competitive inhibitor. In accordance with this prediction, quinpirole inhibited the increase of A-type K⁺ current density caused by sulpiride (Figure 3E; vehicle: 445.5 ± 108 pA/pF; chronic Sul: 710 ± 66 pA/pF; p < 0.05; chronic Quin: 498 ± 58 pA/pF; chronic Sul + Quin: 431 ± 40 pA/pF; p > 0.05). Since two D2 receptor antagonists increase A-type channel activity, and a selective D2 receptor agonist interferes with this channel regulation, active D2 autoreceptors must act over days to reduce A-type K⁺ channel activity.

cAMP-PKA signaling mediates long-term A-type K⁺ channel regulation

D2 autoreceptors on DA neurons are coupled to G_i and inhibition of adenylate cyclase (). Therefore, D2 antagonists such as sulpiride relieve this inhibition and increase cAMP to stimulate Protein Kinase A (PKA, cAMP-dependent protein kinase). To test for involvement of this pathway, we first examined whether the nonhydrolyzable cAMP analog 8-Br-cAMP alters the long-term action of sulpiride. Chronic treatment of cultured DA neurons with 1 mM 8-Br-cAMP prevented further upregulation of A-type channels by sulpiride (Figure 4A; chronic 8-Br-cAMP: 440 ± 96 pA/pF; chronic Sul + 8-Br-cAMP: 381 ± 59 pA/pF; p > 0.05). This occlusion of the sulpiride effect suggests that cAMP is sufficient to produce long-term enhancement of A-type K⁺ current density.

Figure 4

Chronic blockade of D autoreceptors upregulates A-type K⁺ currents through cAMP-PKA signaling pathway in cultured DA neurons. A, 8-Br-cAMP (1 mM) prevents further upregulation of A-type K⁺ current density by sulpiride. B, The PKA inhibitor H-89 (1 μM) (more ...)

We then tested for a role of PKA in long-term upregulation of A-type channels. Chronic treatment with 1 μM H-89, a PKA inhibitor, did not affect A-type K⁺ current density (vehicle: 379 ± 28 pA/pF; chronic H-89: 403 ± 15 pA/pF; p > 0.05). This suggests that there is little baseline activation of PKA in our cultures. However, H-89 inhibited the sulpiride-induced increase in A-type channel activity without causing an effect on its own (Figure 4B; chronic Sul: 576 ± 60 pA/pF; chronic Sul + H-89: 441 ± 36 pA/pF; p < 0.05, ANOVA analysis). Thus, the cAMP-PKA pathway is necessary and sufficient for the long-term regulation of A-type channel activity by sulpiride. The involvement of this signaling further supports the conclusion that D2 autoreceptors are responsible for the long-term regulation of A-type channels.

A-type K⁺ channels regulate both the rate and the regularity of pacemaker activity

The increase in A-type channel activity produced by blocking D2 receptors appears to arise from a change in channel number rather than gating. Voltage clamp experiments showed that the voltage dependence of activation and steady state inactivation of A-type K⁺ current were not affected by chronic sulpiride treatment (Figure 5A, B). Likewise, the kinetics of recovery from inactivation did not change (Figure 5C,D). Furthermore, the time to reach the peak current at +60 mV, an indicator of rate of activation, and the rate of inactivation of A-type K⁺ current were similar in vehicle and sulpiride treated neurons (Figure 5E, F). Thus, A-type K⁺ channel gating was not altered by chronic sulpiride. Because membrane surface area measured as capacitance was not changed by chronic sulpiride treatment (vehicle: 24.4 ± 1.2 pF, n = 25; chronic Sul: 23.6 ± 1.5 pF, n = 25), the increase in the fast inactivating current with prolonged sulpiride treatment is due to an increase in the number of functional A-type K⁺ channels.

Figure 5

Upregulation of A-type K⁺ channel activity occurs without changing gating. A, Example steady state inactivation current traces. Prepulses were delivered in 20 mV steps from -140 mV and current was measured at +60 mV. The holding potential was -90 mV. (more ...)

We then set out to determine whether the change in A-type K⁺ channel number alone is responsible for altered spontaneous firing. Since the interspike interval is proportional to A-type channel number in DA neurons (; ), we recorded spontaneous activity and A-type K⁺ currents in the same DA neurons after chronic treatment with vehicle or sulpiride. Vehicle-treated DA neurons displayed mean firing frequencies from 1.5 to 4.0 Hz and A-type current densities between 250 and 520 pA/pF at +60 mV (n = 8). However, prolonged sulpiride treatment tended to decrease firing frequency (0.3-2.5 Hz) and increase A-type current density (360-1500 pA/pF at +60 mV (n = 8). The mean frequency was plotted against the mean A-type current density from the two experimental groups (Figure 6A). The inverse relationship between A-type current density and frequency supports the conclusion that upregulation of A-type channels is responsible for the slowing of intrinsic pacemaking induced by chronic blockade of D2 autoreceptors.

Figure 6

Reversible recapitulation of the effect of chronic autoreceptor blockade on DA pacemaker activity by virtual A-type K⁺ channels. A, Pacemaker frequency is inversely proportional to A-type K⁺ current density. Spontaneous firing activity and K⁺ currents (more ...)

Dynamic clamp experiments were performed to directly determine the effect of upregulating A-type K⁺ channels on pacemaker activity. Dynamic clamp is a technique in which currents from a computationally modeled conductance can be introduced in real time to living cells (). It has the advantage of being quickly reversible(i.e. the dynamic clamp can be turned on and off) and does not suffer from the nonspecificity and complexities (i.e. gating and voltage dependence) associated with pharmacological agents. Using this approach we set out to determine whether manipulation of a virtual A-type K⁺ current alone could mimic all or only some of the effects of chronic drug treatment on DA neurons. For this purpose we employed our model A-type current that had been derived using voltage clamp data from DA neurons () and incorporated into the dynamic clamp system (). Whole cell patch recordings were used to test how virtual A-type K⁺ conductance, quantified in terms of the maximum conductance in the gating model (

), influenced the rate and regularity of DA neuron pacemaking activity.

Dynamic clamp recordings showed that adding virtual A-type K⁺ channels to a cultured DA neuron decreased firing frequency (Figure 6B). Indeed, the mean interspike interval increased in proportion to the added A-type K⁺ channel conductance (supplementary material 1). Furthermore, the slowing in action potential frequency induced by the addition of dynamic clamp-mediated A-type K⁺ current was reversible (Figure 6B) and reproducible across independent experiments (Figure 6C; control: 303 ± 50 ms; +150 nS: 577 ± 109 ms; p < 0.05). Thus, increasing A-type K⁺ channel activity is sufficient to slow DA neuron pacemaker activity.

Further analysis of dynamic clamp results showed that adding virtual A-type channels also increased the irregularity of spontaneous pacemaking. Figure 6B shows that adding and then removing conductance was sufficient to reversibly broaden and skew the interspike interval distribution. This effect is quantified as a reproducible increase in the coefficient of variation for the interspike interval (Figure 6D; control: 0.28 ± 0.06; +150 nS: 0.57 ± 0.09; p < 0.05).

The computational model of A-type currents implemented in the dynamic clamp was based on differential equations describing macroscopic channel gating and so noise originating from A-type channels does not change with engagement of the dynamic clamp. Therefore, we can draw two conclusions from these experiments. First, increasing the number of functional A-type channels is sufficient to explain the long-term effects of chronic blockade of D2 autoreceptors on both frequency and irregularity of DA neuron pacemaker activity. Second, the change in regularity must reflect an indirect effect of A-type K⁺ channels that unmasks noise from other channel types that are not regulated by D2 receptors.

The above analysis relies on dynamic clamp experiments performed with conventional whole cell recording. Under these conditions the cytoplasm is dialyzed with a pipette solution, which could alter the contribution of A-type channels to pacemaking activity. Therefore, we repeated the above dynamic clamp experiment, but used perforated patching to ensure that cells were metabolically intact. Under such conditions, cultured dopamine neuron firing frequency is lower than in our whole cell recordings (), possibly because Ca²⁺ chelator in the whole cell recording solution reduces inactivation of the pacemaker Ca²⁺ channels or activation of Ca²⁺-activated K⁺ channels. Despite this difference, we found that adding virtual A-type channels reversibly increased the ISI and CV_ISI in each of the 6 dopamine neurons studied (Fig. 7A-C). Thus, we reproduced the effects originally detected with conventional whole cell recording with the perforated patch clamp technique.

Figure 7

A-type channels control the rate and regularity of pacemaker activity in perforated patch clamped dopamine neurons. A, Action potential activity before (left) and after (right) adding 200 nS of virtual A-type channel conductance. Change in mean ISI ( (more ...)

We then extended our dynamic clamp studies by subtracting A-type channel conductance. These independent experiments showed that reducing A-type channel activity lowered both the ISI and CV_ISI in every dopamine neuron tested (Fig. 7C-E, n=6). Thus, perforated patch clamp recordings, along with dynamic clamp, show that the rate and regularity of dopamine neuron pacemaker activity are inversely proportional to A-type channel activity.

Discussion

D2 autoreceptors acutely inhibit DA neurons and so D2 antagonists are associated with short-term excitation. However, cultured DA neuron experiments in this study show that D2 antagonists operate over days to decrease the rate and regularity of DA neuron intrinsic pacemaker activity. This implies that autoreceptors are active in this period and normally have the long-term effect of increasing firing rate and regularity (supplementary material 2). The change in spontaneous activity reflects regulation of A-type channel activity, which also likely affects the impact of synaptic potentials (). Hence, DA neuron spiking, which is driven by intrinsic mechanisms and synaptic inputs, will be more autonomous, rapid and consistent because of the long-term regulation of A-type channels by active D2 autoreceptors. This is relevant because robust, regular activity can serve as a baseline for discrimination of bursts of DA neuron activity that encode unexpected reward (Schultz, , ). Furthermore, the long-term A-type channel regulation by active autoreceptors is striking because it opposes the known short-term effects of D2 receptors and cAMP on channel gating (supplementary material 3). Thus, the control of DA neuron excitability changes with the time scale of D2 autoreceptor activation: over seconds K⁺ channel opening is induced, while receptor function over days suppresses K⁺ channel number. Finally, our findings indicate that it is the blockade of the latter response that accounts for the long-term dampening of DA neuron pacemaker activity induced by chronic in vivo treatment with haloperidol ().

Our experiments show that A-type K⁺ channels control reliability, as well as frequency, of pacemaker activity in cultured DA neurons. Originally, we hypothesized that the modification of pacemaker regularity by chronic haloperidol seen in vivo and with acutely dissociated cells (; ) was caused by control of a different channel type. Such a model was consistent with the expectation that an increase in channel noise could produce more irregular firing, but that the increase in the number of functional A-type K⁺ channels produced by blocking D2 receptors would reduce the noise in the A-type K⁺ current (). However, since we could acutely and reversibly modify both the rate and regularity of pacemaker activity with the addition and subtraction of dynamic clamp-generated noiseless A-type channels, we conclude that these channels alone account for the long-term regulation by D2 autoreceptors.

We suggest that the smaller net inward current below threshold produced by increased outward A-type current has two consequences: pacemaking is slowed and the impact of fluctuations produced by other channels is amplified (supplementary material2). Of course, the impact of the latter fluctuations might depend on experimental conditions (e.g. DA neuron firing is more regular in slices from older animals than in our cultures). However, in vivo there are many potential sources of irregularity, including noise in the channels that mediate pacemaker activity, spontaneous hyperpolarizations that are most prevalent in immature animals (), and synaptic channels. Regardless of the basis of the complexity in DA neuron activity that occurs in the intact brain, our results with cultured neurons suggest that A-type channels serve dual roles as controllers of firing frequency and consistency.

Although long-term changes in DA neuron activity by D2 antagonists have been attributed to changes in synaptic circuits, the demonstration of autoreceptor-induced remodeling of intrinsic pacemaker activity in cultured DA neurons leads us to conclude that plasticity occurs within DA neurons themselves. Lesions that affected in vivo extracellular recordings () may have acted indirectly to disrupt conditions that are permissive for the control of DA neuron channel expression by autoreceptors. Furthermore, our results show that there must be sufficient DA released by ongoing activity in static cultures to activate D2 autoreceptors. Nanomolar concentrations of DA acutely hyperpolarize cultured DA neurons (). However, the sensitivity to DA is expected to vary among D2 receptor-induced effects depending on diverse downstream signaling pathways, the different cellular targets used for controlling channel gating and number, and spare receptors. Therefore, the long-term control of DA neuron excitability could be more sensitive to the transmitter than short-term effects on channel gating. It is also possible that changes in D2 autoreceptor function induced by unexpected reward or addictive drugs are integrated over long periods to affect channel expression and, hence, future firing activity. Likewise, the regulation described here could be relevant during treatment of schizophrenia because all antipsychotic drugs are D2 receptor antagonists and take days to exert their therapeutic effects ().

Our results, along with previous publications, suggest a mechanism for the long-term D2 receptor effect on A-type channels. We showed that this effect is mimicked by 8-Br-cAMP and blocked by the PKA inhibitor H-89. Each of these pharmacological agents has limitations in specificity: 8-Br-cAMP analog activates other cAMP targets(e.g. cyclic nucleotide-gated channels) and H-89 at high concentrations can inhibit kinases in addition to PKA. However, there is no known target that shares sensitivity to this combination of drugs, and the cAMP-PKA pathway is a known target of D2 receptors. Furthermore, the Kv4.3 gene promoter contains a binding site for the cAMP/PKA-sensitive transcription enhancer CREB (). Finally, in vivo experiments with haloperidol suggest that a change in Kv4.3 mRNA expression could underlie the long-term A-type channel regulation in DA neurons (). Therefore, the long-term change in DA neuron pacemaker activity may be mediated by D2 receptors acting via cAMP/PKA phosphorylation of CREB to control Kv4.3 gene transcription leading to changes in channel mRNA, protein, and activity.

Formats:

PubMed articles by these authors

PubMed related articles

Recent Activity

Links

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information